Orforglipron
RESTRAIN-SUI
Eli Lilly · Phase 3 · Recruiting · Enrollment 1000
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Orforglipron (GZS1) | n/r | n/r | n/r | n/r | n/r |
| Placebo (GZS1) | n/r | n/r | n/r | n/r | n/r |
| Orforglipron (GZS2) | n/r | n/r | n/r | n/r | n/r |
| Placebo (GZS2) | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.